1.Conville PS., Witebsky FG. Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces, and Other Aerobic Actionmycetes. In:. Murray PR, Baron EJ, editors. Manual of clinical microbiology. 9th ed.Washington DC: ASM Press;2007. p. 519–26.
2.Tsukamura M., Kawakami K. Lung infection caused by Gordona aurantiaca (Rhodococcus aurantiacus). J Clin Microbiol. 1982. 16:604–7.
3.Tsukamura M., Hikosaka K., Nishimura K., Hara S. Severe progressive subcutaneous abscesses and necrotizing tenosynovitis caused by Rhodococcus aurantiacus. J Clin Microbiol. 1988. 26:201–5.
4.Prinz G., Ban E., Fekete S., Szabo Z. Meningitis caused by Gordona aurantiaca (Rhodococcus aurantiacus). J Clin Microbiol. 1985. 22:472–4.
5.Lai KK. A cancer patient with central venous catheter-related sepsis caused by Tsukamurella paurometabolum (Gordona aurantiaca). Clin Infect Dis. 1993. 17:285–7.
6.Shapiro CL., Haft RF., Gantz NM., Doern GV., Christenson JC., O'Brien R, et al. Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer. Clin Infect Dis. 1992. 14:200–3.
7.Chong Y., Lee K., Chon CY., Kim MJ., Kwon OH., Lee HJ. Tsukamurella inchonensis bacteremia in a patient who ingested Hydrochloric acid. Clin Infect Dis. 1997. 24:1267–8.
8.Relman DA. Universal bacterial 16S rRNA amplification and sequencing. Persing DH, Smith TF, editors. Diagnostic molecular microbiology principles and applications. 1st ed.Washington DC: ASM Press;1993. p. 489–95.
9.National Committee for Clinical Laboratory Standards. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. NCCLS document MM18-A. Wayne, PA: Clinical and Laboratory Standards Institute;2008.
10.National Committee for Clinical Laboratory Standards. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes; approved standard. NCCLS document M24-A. Wayne, PA: Clinical and Laboratory Standards Institute;2003.
11.National Committee for Clinical Laboratory Standards. Principles and procedures for blood cultures; approved guideline. NCCLS document M47-A. Wayne, PA: Clinical and Laboratory Standards Institute;2007.
12.Auerbach SB., McNeil MM., Brown JM., Lasker BA., Jarvis WR. Outbreak of pseudoinfection with Tsukamurella paurometabolum traced to laboratory contamination: efficacy of joint epidemiological and laboratory investigation. Clin Infect Dis. 1992. 14:1015–22.
13.Schwartz MA., Tabet SR., Collier AC., Wallis CK., Carlson LC., Nguyen TT, et al. Central venous catheter-related bacteremia due to Tsukamurella species in the immunocompromised host: a case series and review of the literature. Clin Infect Dis. 2002. 35:e72–7.
14.McNeil MM., Brown JM. The medically important aerobic Actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994. 7:357–417.
15.Kattar MM., Cookson BT., Carlson LD., Stiglich SK., Schwartz MA., Nguyen TT, et al. Tsukamurella strandjordae sp. nov., a proposed new species causing sepsis. J Clin Microbiol. 2001. 39:1467–76.
16.Yassin AF., Rainey FA., Brzezinka H., Burghardt J., Rifai M., Seifert P, et al. Tsukamurella pulmonis sp. nov. Int J Syst Bacteriol. 1996. 46:429–36.
17.Bizet C., Barreau C., Harmant C., Nowakowski M., Pietfroid A. Identification of Rhodococcus, Gordona and Dietzia species using carbon source utilization tests (“Biotype-100” strips). Res Microbiol. 1997. 148:799–809.